Collectively, these studies indicate that rationally designed TB vaccines should generate immune responses that prevent the establishment of infection and/or provide sterilizing immunity by inducing both lung CD4+ TRM and CD8+ TRM in the lungs. The gene discussed is CD8A; the disease is infection.